Nationality: American | Year of Birth: 1967
David has been a Board Member of the Cosmo Pharmaceuticals NV since 2021.
Mr. David Maris is the founder of Phalanx Investment Partners, LLC, an investment advisor, since January 2020. Mr. Maris has been an advisor to Iacta Pharmaceuticals, since 2021, and was a member of the board of directors of Amphastar Pharmaceuticals (NASDAQ: AMPH) from 2020 until 2021, where he also served on the audit committee.
From December 2015 to December 2019, he was managing director and equity research analyst at Wells Fargo Securities, LLC, an investment bank. Before serving at Wells Fargo Securities, LLC, he served as a managing director and equity research analyst at Bank of Montreal, an investment bank, from January 2013 to December 2015. Prior to serving Bank of Montreal and Wells Fargo Securities, LLC, he served as a healthcare industry equity analyst for several other investment banks, including Credit Agricole – CLSA, Bank of America, Credit Suisse, Bear Stearns, and Aros Securities.
Mr. Maris also served as a healthcare portfolio manager for Balaysny Asset Management and currently serves as a member of the American Finance Association and National Association of Corporate Directors.
Mr. David Maris holds a B.A. from the University of Delaware and an M.B.A. from Vanderbilt University’s Owen Graduate School of Management.